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Summary
This study investigates the role of 3.0T R2* imaging for
measuring cardiac iron overload. Experiments were con-
ducted on calibrated phantoms and sickle cell disease
(SCD) patients. R2* imaging at 3.0T enabled assessment
of wide range of iron concentrations. R2* values at 3.0T
were about double of those at 1.5T. Myocardial R2*
showed weak and strong correlations with hepatic R2*
and serum ferritin, respectively. In conclusion, R2* ima-
ging at 3.0T is promising technique for assessing cardiac
iron overload in SCD with high sensitivity and
reproducibility.
Background
Heart failure due to cardiac iron overload is the leading
cause of death in sickle cell disease (SCD) patients who
receive frequent blood transfusion. CMR R2* imaging at
1.5T has been established for assessing iron overload.
However, recent rapid growth in use of 3.0T scanners
raises the question whether quantitative iron assessment
will be possible at 3.0T, and what advantages are
expected, which is investigated in this study.
Methods
Ten gel-based phantoms were prepared with different
iron concentrations (0-225µmol/g). The phantoms were
imaged with optimized T2*-weighted sequence on Sie-
mens 1.5T and 3.0T scanners (Fig.1). T2* was measured
using monoexponential curve fitting (R2*=1000/T2*).
The optimized 3.0T sequence was tested on 9 SCD
patients. Imaging parameters: TR=200ms,
matrix=256×192, FOV=380×285mm
2, 10 echoes
(TE=1.9-21.8ms), scan time=15s. Mid-ventricular short-
axis heart slices at late diastole, and mid-liver transaxial
slices were acquired (Fig.2). Average signal intensities
were measured inside regions of the heart (septal wall)
and liver. Regression analysis was conducted to study
relationships between R2* at 1.5T, R2* at 3.0T, and iron
concentration in the phantoms; and between myocardial
R2*, liver R2*, and serum ferritin in patients. Bland-Alt-
man analysis was conducted to measure inter- and
intra-observer variabilities.
Results
R2* values at 3.0T were about double of those at 1.5T.
At 1.5T/3.0T, R2*(T2*) ranged from 50.7/112.4 1/s
(19.7/8.9ms) to 158.7/344.8 1/s (6.3/2.9ms) at iron con-
centrations of 50 and 225µmol/g, respectively. T2* and
R2* showed decreasing nonlinear and increasing linear
(r=0.98/0.99) relationships, respectively, with iron con-
centration (Fig.1). At 1.5T, R2* of the lowest-concentra-
tion phantom (25 µmol/g) was almost zero. However,
R2*(T2*) of this phantom was 34.8 1/s (28.7ms) at 3.0T,
which was in agreement with the established linear rela-
tionship. In patients, myocardial/hepatic R2*(T2*) ran-
ged from 32.6/78.7 1/s (30.7/12.7ms) to 78.1/243.9 1/s
(12.8/4.1ms). The patients’ serum ferritin ranged from
50 to 3162ng/ml. Myocardial R2* showed weak (r=0.78)
and strong (r=0.91) correlations with hepatic R2* and
serum ferritin, respectively. Hepatic R2* had week corre-
lation with serum ferritin (r=0.66). Bland-Altman
showed no bias between repeated R2* measurements.
Conclusions
R2* imaging at 3.0T enabled assessment of wide range
of iron concentrations. However, it requires perfect
shimming and very short echo times. The larger liver
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tion in liver. The good correlation between myocardial
R2* and serum ferritin confirms that serum ferritin pro-
vides estimate of total body iron balance and correlates
with R2* in absence of liver disease, inflammation, or
infection. However, serum ferritin, by itself, is not reli-
able indicator of cardiac iron overload. In conclusion,
R2* measurement at 3.0T is promising technique for
assessing cardiac iron overload in SCD with high sensi-
tivity and reproducibility.
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